Plasmid-borne extended-spectrum β-lactamase in a clinical isolate of Acinetobacter baumannii

References

1. Bergogne-Berezin E. 2001; The increasing role of Acinetobacter species as nosocomial pathogens. Curr Infect Dis Rep 3:440–444 [CrossRef]
   [Google Scholar]
2. Bergogne-Berezin E., Towner K. J. 1996; Acinetobacter spp.as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–165
   [Google Scholar]
3. Bouvet P. J. M., Grimont P. A. D. 1987; Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 138:569–578 [CrossRef]
   [Google Scholar]
4. Dy M. E., Nord J. A., LaBombardi V. J., Kislak J. W. 1999; The emergence of resistant strains of Acinetobacter baumannii : clinical and infection control implications. Infect Control Hosp Epidemiol 20:565–567 [CrossRef]
   [Google Scholar]
5. Jarlier V., Nicolas M. H., Fournier G., Philippon A. 1988; Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae : hospital prevalence and susceptibility patterns. Rev Infect Dis 10:867–878 [CrossRef]
   [Google Scholar]
6. Joshi S. G. 1998; Assignment of antibiotic resistance to naturally occurring plasmids from clinical isolates of Acinetobacter species. PhD thesis University of Pune; Pune, India:
7. Joshi S. G., Litake G. M., Niphadkar K. B., Ghole V. S. 2003; Multidrug resistant Acinetobacter baumannii isolates from a teaching hospital. J Infect Chemother 9:187–190 [CrossRef]
   [Google Scholar]
8. Levin A. S., Levy C. E., Manrique A. E. I., Medeiros E. A. S., Costa S. F. 2003; Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 21:58–62 [CrossRef]
   [Google Scholar]
9. Mulvey M. R., Soule G., Boyd D., Demczuk W., Ahmed R. 2003; Characterization of the first extended-spectrum β-lactamase-producing Salmonella isolate identified in Canada.Multi-provincial Salmonella typhimurium Case Control Study Group. J Clin Microbiol 41:460–462 [CrossRef]
   [Google Scholar]
10. NCCLS 1997 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically . Approved Standard M7-A4 Villanova, PA: National Committee for Clinical Laboratory Standards;
    [Google Scholar]
11. Perilli M., Felici A., Oratore A., Cornaglia G., Bonfiglio G., Rossolini G. M., Amicosante G. 1996; Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother 40:715–719
    [Google Scholar]
12. Poirel L., Karim A., Mercat A., Le Thomas I., Vahaboglu H., Richard C., Nordmann P. 1999; Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother 43:157–158 [CrossRef]
    [Google Scholar]
13. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: a Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
14. Stanisich V. A. 1988; Identification and analysis of plasmids at the genetic level. Methods Microbiol 21:11–48
    [Google Scholar]
15. Vahaboglu H., Coskunkan F., Tansel O. & 10 other authors; 2001; Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacte r spp.and Pseudomonas aeruginosa strains. J Med Microbiol 50:642–645
    [Google Scholar]
16. Von Graevenitz A. 1995; Acinetobacter , Alcaligenes , Moraxella and other non-fermentative gram-negative bacteria. In Manual of Clinical Microbiology pp 520–532Edited by Murray P. J., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. Washington, DC: American Society of Microbiology;
    [Google Scholar]
17. Willets N. 1988; Conjugation. Methods Microbiol 21:49–75
    [Google Scholar]